IO-14

N/A

Report date: 2025/01/26 19:21:49
NME

Base Information

Drug NameIO-14
Drug Alias Nameimmuno-oncology drug 14 (KSQ Therapeutics)IO-14
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKSQ Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKSQ Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A